Sutro Biopharma, Inc 10-K for FY2022
Sutro Biopharma, Inc. (STRO)
10-K
2023-03-30
For: 2022-12-31
View Original
Added on
April 11, 2026
About this 10-K
Sutro Biopharma, Inc filed this 10-K on March 30, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $67.77M
- up 9.5% from $61.88M a year earlier
- Net loss
- $119.2M
- compared with a net loss of $105.54M a year earlier
- Diluted EPS
- -$2.35
- compared with -$2.29 a year earlier